Fumitoshi Terauchi

1.1k total citations · 1 hit paper
31 papers, 716 citations indexed

About

Fumitoshi Terauchi is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Fumitoshi Terauchi has authored 31 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 12 papers in Surgery and 9 papers in Obstetrics and Gynecology. Recurrent topics in Fumitoshi Terauchi's work include Ovarian cancer diagnosis and treatment (21 papers), Intraperitoneal and Appendiceal Malignancies (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Fumitoshi Terauchi is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Intraperitoneal and Appendiceal Malignancies (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Fumitoshi Terauchi collaborates with scholars based in Japan, France and Italy. Fumitoshi Terauchi's co-authors include Keiichi Isaka, Toru Sugiyama, Makoto Yasuda, Hirotaka Nishi, Fumiaki Takahashi, Noriyuki Katsumata, Seiji Isonishi, Toshiko Jobo, Eizo Kimura and Daisuke Aoki and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Fumitoshi Terauchi

29 papers receiving 699 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

2013 331 citations Noriyuki Katsumata, Makoto Yasuda et al. profile →

Peers

Countries citing papers authored by Fumitoshi Terauchi

Since Specialization

Citations

This map shows the geographic impact of Fumitoshi Terauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitoshi Terauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitoshi Terauchi more than expected).

Fields of papers citing papers by Fumitoshi Terauchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitoshi Terauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitoshi Terauchi. The network helps show where Fumitoshi Terauchi may publish in the future.

Co-authorship network of co-authors of Fumitoshi Terauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitoshi Terauchi. A scholar is included among the top collaborators of Fumitoshi Terauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitoshi Terauchi. Fumitoshi Terauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve 2021 ·World Journal of Surgical Oncology ·Hiroe Ito, (unknown), Fumitoshi Terauchi, Keiichi Isaka	5
2	The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG 2020 ·Journal of Gynecologic Oncology ·Eiji Kondo, Tsutomu Tabata, Nao Suzuki, Daisuke Aoki, Hideaki Yahata, (unknown), Osamu Tokuyama, Keiichi Fujiwara, Eizo Kimura, Fumitoshi Terauchi, Toshiyuki Sumi, Aikou Okamoto, Nobuo Yaegashi, Takayuki Enomoto, Toru Sugiyama	5
3	The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study (JGOG3017/GCIG). 2019 ·Journal of Clinical Oncology ·Eiji Kondo, Tsutomu Tabata, Nao Suzuki, Daisuke Aoki, Osamu Tokuyama, Kiyoko Kato, Tetsutaro Hamano, (unknown), Keiichi Fujiwara, Eizo Kimura, Fumitoshi Terauchi, Toshiyuki Sumi, Aikou Okamoto, Nobuo Yaegashi, Takayuki Enomoto, Toru Sugiyama	1
4	Profiling analysis of circulating microRNA expression in cervical cancer 2016 ·Molecular and Clinical Oncology ·(unknown), Hirotaka Nishi, Toru Sasaki, (unknown), Fumitoshi Terauchi, Keiichi Isaka	49
5	Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery 2015 ·Medicine ·Takeshi Nagai, Hisashi Oshiro, Yasukazu Sagawa, Kentaro Sakamaki, Fumitoshi Terauchi, Toshitaka Nagao	6
6	Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells 2015 ·Oncology Reports ·Hirotaka Nishi, Toru Sasaki, (unknown), Fumitoshi Terauchi, Takeshi Nagai, Toshitaka Nagao, Keiichi Isaka	18
7	A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix 2014 ·International Journal of Clinical Oncology ·Toru Sasaki, Hirotaka Nishi, Chie Nagata, Takeshi Nagai, Toshitaka Nagao, Fumitoshi Terauchi, Keiichi Isaka	5
8	Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan 2014 ·International Journal of Clinical Oncology ·(unknown), (unknown), Kazuaki Takahashi, Masaharu Fukunaga, Mitsutoshi Iwashita, Yoichi Kobayashi, (unknown), (unknown), Fumitoshi Terauchi, Kazushige Kiguchi, Daisuke Aoki, (unknown), Hiroyuki Yoshikawa, Toyomi Satoh, Toshiko Jobo, Hiroyuki Fujiwara, Yuji Takei, Seiryu Kamoi, Yasuhisa Terao, Seiji Isonishi	4
9	Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016) 2013 ·Annals of Oncology ·Kenichi Harano, Fumitoshi Terauchi, Noriyuki Katsumata, Fumiaki Takahashi, Makoto Yasuda, (unknown), Masashi Takano, Yasuhiro Yamamoto, Toru Sugiyama	20
10	Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer? Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial 2011 ·International Journal of Gynecological Cancer ·(unknown), Toru Sugiyama, Tadahiro Shoji, Hirofumi Michimae, Noriyuki Katsumata, Daisuke Aoki, Fumitoshi Terauchi, Toshiko Jobo, Kazunori Ochiai, Makoto Yasuda	5
11	Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer 2010 ·Oncology Letters ·Fumitoshi Terauchi, Aikou Okamoto, Yumiko Wada, (unknown), Toru Sasaki, (unknown), Yasukazu Sagawa, Hirotaka Nishi, Keiichi Isaka	9
12	A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology 2009 ·Journal of obstetrics and gynaecology research ·Yukari Kobayashi, Fumitoshi Terauchi, Hirotaka Nishi, (unknown), (unknown), Keiichi Isaka	3
13	Pilot Study on Transdiaphragmatic Thoracoscopic-Assisted Pleural Biopsy and Intrathoracic Washing Cytology for Stage IIIc Ovarian Cancer With Diaphragmatic Metastases 2009 ·International Journal of Gynecological Cancer ·Fumitoshi Terauchi, Yukari Kobayashi, (unknown), (unknown), Hirotaka Nishi, Atsuya Fujito, Keiichi Isaka	8
14	Early growth response‐1 mediates downregulation of telomerase in cervical cancer 2008 ·Cancer Science ·(unknown), Hirotaka Nishi, Satoru Kyo, Fumitoshi Terauchi, Koji Yamazawa, (unknown), Masaki Inoue, Keiichi Isaka	20
15	Prognostic factor on optimal debulking surgery by maximum effort for stage IIIC epithelial ovarian cancer 2008 ·Journal of obstetrics and gynaecology research ·Fumitoshi Terauchi, Hirotaka Nishi, (unknown), Yukari Kobayashi, (unknown), (unknown), Atsuya Fujito, (unknown), Keiichi Isaka	4
16	Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer 2007 ·Human Reproduction ·Koji Yamazawa, Masaru Hirai, Atsuya Fujito, Hirotaka Nishi, Fumitoshi Terauchi, H Ishikura, Makio Shozu, Keiichi Isaka	121
17	Sclerosing stromal tumor of the ovary with elevated CA125 2005 ·Journal of obstetrics and gynaecology research ·Fumitoshi Terauchi, (unknown), (unknown), Yukari Kobayashi, (unknown), Toshiaki Oharaseki, (unknown)	13
18	[Evaluation of QOL with orally disintegrating antiemetic tablets in outpatient chemotherapy]. 2003 ·PubMed ·Fumitoshi Terauchi, (unknown), (unknown), Yukari Kobayashi, (unknown), (unknown), (unknown), (unknown), (unknown)	2
19	Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study 2003 ·International Journal of Clinical Oncology ·Fumitoshi Terauchi, Takayuki Hirano, (unknown), Kazuo Masaki, Yasuhiro Yamamoto, (unknown), (unknown)	6
20	Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm 2002 ·International Journal of Clinical Oncology ·Fumitoshi Terauchi, (unknown), Yasuhiro Yamamoto, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact